Synergistic upregulation of interleukin-8 secretion from pulmonary epithelial cells by direct and monocyte-dependent effects of respiratory syncytial virus infection

Journal of Virology

Volumn 74, Issue 18, 2000, Pages 8425-8433

  Thomas, L H ^a   Wickremasinghe, M I Y ^a   Sharland, M ^a   Friedland, J S ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL VIABILITY; CYTOKINE RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; LUNG ALVEOLUS EPITHELIUM; MONOCYTE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; VIROGENESIS; VIRUS INFECTION; VIRUS PATHOGENESIS;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BRONCHI; CELL LINE; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTERLEUKIN-8; MONOCYTES; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;

EID: 0033862902     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.18.8425-8433.2000     Document Type: Article

References (74)

1. Pathological changes in virus infections of the lower respiratory tract in children
2. Ribavirin and bronchiolitis: Variation in use in the UK
3. Interleukin-8, interleukin-6, and soluble turnout necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus
4. Cytokine (IL-8, IL-6, TNF-α) and soluble TNF receptor-I release from human peripheral blood mononuclear cells after respiratory syncytial virus infection
5. Effect of respiratory syncytial virus-antibody complexes on cytokine (IL-8, IL-6, TNF-α) release and respiratory burst activity in human granulocytes
6. Function and activation of NF-κB in the immune system
7. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils
8. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8
9. Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1 and interleukin-6
10. Cytokine (tumour necrosis factor, IL-6 and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages
11. RSV infection of human airway epithelial cells causes production of the β-chemokine RANTES
12. Airway epithelial cell-induced activation of monocles and eosinophils in respiratory, syncytial viral infection
13. RANTES and related chemokines activate human basophil granulocytes through different G protein coupled receptors
14. Elevated plasma interleukin-8 in respiratory syncytial virus bronchiolitis
15. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis
16. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
17. A promoter recruitment mechanism for tumor necrosis factor-a-induced interleukin-8 transcription in type II pulmonary epithelial cells
18. Prospects for a respiratory syncytial virus vaccine
19. Control of IκB-α proteolysis by site-specific, signal induced phosphorylation
20. Microplaque immunoperoxidase detection of infectious respiratory syncytial virus in the lungs of infected mice
21. Single-step method for RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
22. Pseudomonas pyocyanin increases interleukin-8 expression by human airway epithelial cells
23. Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo
24. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infections among hospitalised adults
25. Characterization of antigen receptor response elements within the interleukin-2 enhancer
26. Fibroblast interleukin 1 beta: Synergistic stimulation by recombinant interleukin 1 and tumor necrosis factor and posttranscriptional regulation
27. Analysis of cells obtained by bronchial lavage of infants with respiratory syncitial virus infection
28. Respiratory syncytial virus and influenza A infections in the hospitalized elderly
29. Inhibition of viral replication reverses respiratory syncitial virus-induced NF-κB activation and interleukin-8 gene expression in A549 cells
30. Mechanism of RSV-induced IL-8 gene expression in A549 cells before viral replication
31. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro
32. Transcriptional activation of the interleukin-8 gene by respiratory syncytial virus infection in alveolar epithelial cells: Nuclear trans-location of the RelA transcription factor as a mechanism producing airway mucosal inflammation
33. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothetium under flow conditions
34. NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses
35. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NF-κB
36. The major component of IκBα proteolysis occurs independently of the proteosome pathway in respiratory syncytial virus-infected pulmonary epithelial cells
37. Inducible translational regulation of the NF-IL6 transcription factor by respiratory syncytial virus infection in pulmonary epithelial cells
38. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release
39. Expression and release of interleukin-8 by human airway smooth muscle cells: Inhibition by Th-2 cytokines and corticosteroids
40. Respiratory syncytial virus disease in infants despite prior administration of an antigenic inactivated vaccine
41. IL-8 release from human neutrophils by the respiratory syncytial virus is independent of viral replication
42. Synergistic transcriptional activation of the IL-8 gene by NF-κB p65 (ReLA) and NF-IL-6
43. 2 and tumor necrosis factor-alpha in endothelial and epithelial cells
44. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes
45. A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells
46. Induction of interleukin (IL)-8 gene expression by respiratory syncytial virus involves activation of nuclear factor (NF)-κB and NF-IL6
47. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor κB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium
48. Transcription factors NF-IL6 and NF-κB synergistically activate transcription of the inflammatory cytokines, interleukin-6 and interleukin-8
49. Demonstration of respiratory, syncytial virus in an autopsy series
50. Respiratory syncytial virus-induced cytokine production by a human bronchial epithelial cell line
51. Nasal cytokine production in viral acute upper respiratory infection of childhood
52. Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus
53. Productive infection of isolated human macrophages by respiratory syncytial virus
54. Autocrine regulation of interleukin-8 by interleukin-1 alpha in respiratory syncytial virus-infected pulmonary epithelial cells in vitro
55. Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus
56. Expression of the cytokine RANTES in human rheumatoid synovial fibroblasts. Differential regulation of RANTES and interleukin-8 genes by inflammatory cytokines
57. Synergistic effect of interleukin-1 beta and tumor necrosis factor alpha on interleukin-8 gene expression in synovial fibroblasts. Evidence that interleukin-8 is the major neutrophil-activating chemokine released in response to monokine activation
58. Selective up-regulation of cytokine-induced RANTES gene expression in lung epithelial cells by overexpression of IkappaBR
59. Stimulus-specific regulation of chemokine secretion involves differential activation of the redox-responsive transcription factors AP-1 and NF-κB
60. RANTES and macrophage inflammatory protein 1α induce the migration and activation of normal human eosinophil granulocytes
61. Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells
62. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES
63. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease
64. Interleukin-8 gene expression by a pulmonary epithelial cell line. A model for cytokine networks in the lung
65. Distinct mechanisms for regulation of the interleukin-8 gene involve synergism and cooperativity between C/EBP and NF-κB
66. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years
67. Monocyte chemotactic protein gene expression by cytokine treated human fibroblasts and endothelial cells
68. IL-4 and IL-13 stimulate human bronchial epithelial cells to release IL-8
69. NF-κB controls expression of inhibitor IκBα: Evidence for an inducible autoregulatory pathway
70. Respiratory syncytial virus infection of neonatal monocytes stimulates synthesis of interferon regulatory factor 1 and interleukin-1β (IL-1β)-converting enzyme and secretion of IL-1β
71. Respiratory syncytial virus-induced RANTES production from human bronchial epithelial cells is dependent on NF-κB nuclear binding and is inhibited by adenovirus-mediated expression of IκBα
72. IκB-β regulates the presistent response in a biphasic activation of NF-κB
73. Interferon gamma induces differential upregulation of alpha and beta chernokine secretion in colonic epithelial cell lines
74. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: Essential role of IL-1 from infected monocytes in a NF-kappa β-dependent network